Increased risk of gastrointestinal lymphoma in carriers of the 657del5 NBS1 gene mutation

International Journal of Cancer

Volumn 119, Issue 12, 2006, Pages 2970-2973

  Steffen, Jan ^a   Maneva, Galina ^b   Popławska, Lidia ^a   Varon, Raymonda ^b   Mioduszewska, Olga ^a   Sperling, Karl ^b  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

657del5 mutations; NBS1; Non Hodgkin lymphoma

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; B CELL LYMPHOMA; BURKITT LYMPHOMA; CANCER INCIDENCE; DIGESTIVE SYSTEM CANCER; EUROPE; FOLLICULAR LYMPHOMA; GASTROINTESTINAL LYMPHOMA; GENE FREQUENCY; GENE MUTATION; GERM LINE; HETEROZYGOTE; HUMAN; INCIDENCE; LYMPHOMA; MAJOR CLINICAL STUDY; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NBS1 GENE; NIJMEGEN BREAKAGE SYNDROME; NONHODGKIN LYMPHOMA; POLAND; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CELL CYCLE PROTEINS; GASTROINTESTINAL NEOPLASMS; GENE FREQUENCY; GERM-LINE MUTATION; HETEROZYGOTE; HUMANS; LYMPHOMA; LYMPHOMA, NON-HODGKIN; MIDDLE AGED; MUTATION; MUTATION, MISSENSE; NUCLEAR PROTEINS; ODDS RATIO; POLAND; RISK FACTORS; SEQUENCE DELETION;

EID: 33751581029     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22280     Document Type: Article

References (34)

1. Varon R, Vissinga C, Platzer M, Cerosaletti KM, Chrzanowska KH, Saar K, Beckmann G, Seemanova E, Cooper PR, Nowak NJ, Stumm M, Weemaes CM, et al. Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell 1998;93:467-76.
2. The International Nijmegen Breakage Syndrome Study Group. Nijmegen breakage syndrome. Arch Dis Child 2000;82:400-6.
3. Digweed M, Sperling K. Nijmegen breakage syndrome: clinical manifestation of defective response to DNA double-strand breaks. DNA Repair 2004;3:1207-17.
4. Varon R, Seemanova E, Chrzanowska K, Hnateyko O, Piekutowska-Abramczuk D, Krajewska-Walasek M, Sykut-Cegielska J, Sperling K, Reis A. Clinical ascertainment of Nijmegen breakage syndrome (NBS) and prevalence of the major mutation, 657del5, in three Slavic populations. Eur J Hum Genet 2000;8:900-2.
5. Stumm M, Neubauer S, Keindorff S, Wegner RD, Wieacker P, Sauer R. High frequency of spontaneous translocations revealed by FISH in cells from patients with the cancer-prone syndromes ataxia telangiectasia and Nijmegen breakage syndrome. Cytogenet Cell Genet 2001;92:186-91.
6. Steffen J, Varon R, Mosor M, Maneva G, Maurer M, Stumm M, Nowakowska D, Rubach M, Kosakowska E, Ruka W, Nowecki Z, Rutkowski P, et al. Increased cancer risk of heterozygotes with NBS1 germline mutations in Poland. Int J Cancer 2004;111:67-71.
7. Stanulla M, Stumm M, Dieckvoss BO, Seidemann K, Schemmel V, Muller Brechlin A, Schrappe M, Welte K, Reiter A. No evidence for a major role of heterozygous deletion 657del5 within the NBS1 gene in the pathogenesis of non-Hodgkin's lymphoma of childhood and adolescence. Br J Haematol 2000;109:117-20.
8. Rischewski J, Bismarck PV, Kabisch H, Janka-Schaub G, Obser T, Schneppenheim R. The common deletion 657del5 in the Nibrin gene is not a major risk factor for B or T non-Hodgkin lymphoma in a pediatric population. Leukemia 2000;14:1528-9.
9. Hama S, Matsuura S, Tauchi H, Sawada J, Kato C, Yamasaki F, Yoshioka H, Sugiyama K, Arita K, Kurisu K, Kamada N, Heike Y, et al. Absence of mutations in the NBS1 gene in B-cell malignant lymphoma patients. Anticancer Res 2000;20:1897-900.
10. Taylor GM, O'Brien HP, Greaves MF, Ravetto PF, Eden OB. Correspondence re: "R. Varon, et al. Mutations in the Nijmegen breakage syndrome gene (NBS1) in childhood acute lymphoblastic leukemia. Cancer Res 61:3570-2, 2001". Cancer Res 2003;63:6563-4.
11. Cerosaletti KM, Morrison VA, Sabath DE, Willerford MD, Concannon P. Mutations and molecular variants of the NBS1 gene in non-Hodgkin lymphoma. Genes Chromosomes Cancer 2002;35:282-6.
12. Soucek P, Gut I, Trneny M, Skovlund E, Grenaker Alnaes G, Kristensen T, Borresen-Dale AL, Kristensen VN. Multiplex single-tube screening for mutations in the Nijmegen breakage syndrome (NBS1) gene in Hodgkin's and non-Hodgkin's lymphoma patients of Slavic origin. Eur J Hum Genet 2003;11:416-9.
13. Resnick IB, Kondratenko I, Pashanov E, Maschan AA, Karachunsky A, Togoev O, Timakov A, Polyakov A, Tverskaya S, Evgrafov O, Roumiantsev AG. 657del5 mutation in the gene for the Nijmegen breakage syndrome (NBS1) in a cohort of Russian children with lymphoid tissue malignancies and controls. Am J Med Genet A 2003;120:174-9.
14. Chrzanowska KH, Piekutowska-Abramczuk D, Popowska E, Gladkowska-Dura M, Maldyk J, Syczewska M, Krajewska-Walasek M, Goryluk-Kozakiewicz B, Bubala H, Gadomski A, Gaworczyk A, Kazanowska B, et al. Carrier frequency of mutation 657del5 in the NBS1 gene in a population of Polish pediatric patients with sporadic lymphoid malignancies. Int J Cancer 2006;118:1269-74.
15. Varon R, Reis A, Henze G, von Einsiedel H, Sperling K, Seeger K. Mutations in the Nijmegen breakage syndrome gene (NBS1) in childhood acute lymphoblastic leukemia (ALL). Cancer Res 2001;61:3570-2.
16. Seemanova E, Sperling K, Neitzel H, Varon R, Hadac J, Butova O, Schrock E, Seeman P, Digweed M. Nijmegen breakage syndrome (NBS) with neurological abnormalities and without chromosomal instability. J Med Genet 2006;43:218-24.
17. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting - Airlie House, Virginia, November 1997. J Clin Oncol 1999;17:3835-49.
18. Dumon-Jones V, Frappart PO, Tong WM, Sajithlal G, Hulla W, Schmid G, Herceg Z, Digweed M, Wang ZQ. Nbn heterozygosity renders mice susceptible to tumor formation and ionizing radiation-induced tumorigenesis. Cancer Res 2003;63:7263-9.
19. Demuth I, Frappart PO, Hildebrand G, Melchers A, Lobitz S, Stockl L, Varon R, Herceg Z, Sperling K, Wang ZQ, Digweed M. An inducible null mutant murine model of Nijmegen breakage syndrome proves the essential function of NBS1 in chromosomal stability and cell viability. Hum Mol Genet 2004;13:2385-97.
20. Robinson JG, Lu L, Dixon K, Bissler JJ. DNA lesion-specific colocalization of the Mre11/Rad50/Nbs1 (MRN) complex and replication protein A (RPA) to repair foci. J Biol Chem 2005;280:12927-34.
21. Kang J, Bronson RT, Xu Y. Targeted disruption of NBS1 reveals its roles in mouse development and DNA repair. EMBO J 2002;21:1447-55.
22. Kracker S, Bergmann Y, Demuth I, Frappart PO, Hildebrand G, Christine R, Wang ZQ, Sperling K, Digweed M, Radbruch A. Nibrin functions in Ig class-switch recombination. Proc Natl Acad Sci USA 2005;102:1584-9.
23. Reina-San-Martin B, Nussenzweig MC, Nussenzweig A, Difilippantonio S. Genomic instability, endoreduplication, and diminished Ig class-switch recombination in B cell lacking Nbsl. Proc Natl Acad Sci USA 2005;102:1590-5.
24. Yabuki M, Fujii MM, Maizels N. The MRE11-RAD50-NBS1 complex accelerates somatic hypermutation and gene conversion of immunoglobulin variable regions. Nat Immunol 2005;6:730-6.
25. Isaacson PG. Gastrointestinal lymphoma. Hum Pathol 1994;25:1020-9.
26. Zucca E, Roggero E, Bertoni F, Cavalli F. Primary extranodal non-Hodgkin's lymphomas, Part 1: Gastrointestinal, cutaneous and genito-urinary lymphomas. Ann Oncol 1997;8:727-37.
27. Borisch B, Raphael M, Swerdlow SH, Jaffe ES. Lymphoproliferative diseases associated with primary immune disorders. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press, 2001. 257-9.
28. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991;338:1175-6.
29. Raphael M, Gentilhomme O, Tulliez M, Byron PA, Diebold J. Histopathologic features of high-grade non-Hodgkin's lymphomas in acquired immunodeficiency syndrome. The French Study Group of Pathology for Human Immunodeficiency Virus-Associated Tumors. Arch Pathol Lab Med 1991;115:15-20.
30. Purtilo DT, Strobach RS, Okano M, Davis JR. Epstein-Barr virus-associated lymphoproliferative disorders. Lab Invest 1992;67:5-23.
31. Hamilton-Dutoit SJ, Raphael M, Audouin J, Diebold J, Lisse I, Pedersen C, Oksenhendler E, Marelle L, Pallesen G. In situ demonstration of Epstein-Barr virus small RNAs (EBER 1) in acquired immunodeficiency syndrome-related lymphomas: correlation with tumor morphology and primary site. Blood 1993;82:619-24.
32. Luppi M, Longo G, Ferrari MG, Ferrara L, Marasca R, Barozzi P, Morselli M, Emilia G, Torelli G. Additional neoplasms and HCV infection in low-grade lymphoma of MALT type. Br J Haematol 1996;94:373-5.
33. Moroz C, Marcus H, Zahavi I, Dinari G. Is coeliac disease a premalignant state? Lancet 1988;2:903-4.
34. Wright DH, Jones DB, Clark H, Mead GM, Hodges E, Howell WM. Is adult-onset coeliac disease due to a low-grade lymphoma of intraepithelial T lymphocytes? Lancet 1991;337:1373-4.